Lv1
60 积分 2025-09-03 加入
Tobacco, Inflammation, and Respiratory Tract Cancer
7个月前
已完结
Unlocking the mechanisms underlying the activity of pembrolizumab plus enfortumab vedotin in patients with urothelial carcinoma
7个月前
已完结
Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis
7个月前
已完结
Prognostic Significance of the Cachexia Index (CXI) in Patients with Cancer: A Systematic Review and Meta-Analysis
7个月前
已完结
Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset
7个月前
已完结
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project
7个月前
已完结
Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022
8个月前
已完结
皖公网安备34019202002308
